India Coronavirus Dispatch: Little evidence to show UK strain is deadlier

India's nagging vaccine challenges, state of the tattoo industry, and tips to nurture a newborn amid the virus-news relevant to the country's fight against Covid-19

Britain, UK, coronavirus, London
A man wears a face mask while he walks in Regent Street, ahead of the new Tier-4 restriction measures, in London
Bharath Manjesh New Delhi
4 min read Last Updated : Dec 22 2020 | 3:02 PM IST
Is the new Covid-19 strain in the UK more dangerous? Are vaccines effective?

Many countries, including India, have halted flights to the UK, after its Prime Minister Boris Johnson announced that a new strain of the coronavirus that is spreading through the country is 70 per cent more infectious than the original. 

How concerned should one be? There is no evidence to support if this variant is more dangerous. Nevertheless, a faster rate of transmission means more people could get infected than before. This in turn could lead to an added burden on an already strained healthcare system, the writer of the article says. 

And, vaccines work against this variant, at least as of now. The new variant has mutations to the spike protein that the three leading vaccines are targeting. But, vaccines produce antibodies against many regions in the spike protein, so it’s unlikely that this change would make the vaccine less effective. Read more here

Explained: How Covid lockdown crippled Indian economy

Here's a summary of how the coronavirus pandemic ravaged the Indian economy as an unprecedented year comes to a close.

The trajectory of an already-slowing Indian economy saw a steep decline in 2020—from contracting an unprecedented 23.9 per cent in the April-June quarter to plunging into a technical recession. All major indicators of growth in the economy were massively impacted, except agriculture, the writer of the article says.  

The April-June quarter figure was not only India’s lowest growth rate since the country started reporting quarterly data in 1996, but also worse than the 21.7 per cent contraction reported by the UK economy in the June quarter, the writer says. How did the government handle a crisis of such mammoth proportions? Read more here

The India-specific challenges that remain for vaccines

The Covid-19 pandemic has likely upended millions of lives in India. As an unprecedented year comes to a close, here’s a quick look at the challenges that remain even though vaccines are hitting the market in several countries such as the US and the UK.

The challenge associated with the Pfizer/BioNTech vaccine is that it needs to be stored at -70 degrees Celsius. This can be hard to achieve in many countries, including India. Meanwhile, researchers are also testing advanced formulations that may allow storage at higher temperatures, writes Souro Chowdhury, a President’s PhD Scholar in the department of chemistry at the Imperial College London, in this article. 

Then there is the scalability too. However, a key advantage of the AstraZeneca vaccine candidate is that it can be stored and transported at 4-8 degrees Celsius. And thanks to AstraZeneca’s tie-up with the world’s largest vaccine-maker–Serum Institute of India–this candidate is highly scalable, the writer says.

For India, the biggest challenge that remains is to approve a safe vaccine as soon as the requisite data becomes available, and in a transparent manner that instils public confidence, the writer says. Read more here

How the pandemic affected the tattoo industry

The tattoo-industry another one that has suffered amid the pandemic as it requires close and physical contact.The writer of the article spoke to Mumbai-based tattoo artist Vikas Malani who admits that his clientèle has definitely shrunken. He says tattooing is ultimately a luxury and people don't want to spend on it right now. Read more here (https://www.thehindu.com/entertainment/art/tattoo-artist-vikas-malani-on-how-covid19-affected-industry/article33385342.ece)

Tips to nurture newborns during the pandemic

From preparing your home for the little one, ensure you have all the necessary supplies, to recognising red flags, Dr Tushar Maniar, dead of department at the Centre for Child Health Nanavati Super Speciality Hospital, gives you nifty tips that will help you sail through the task of nurturing a newborn during the pandemic. Read more here

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

Next Story